These 3 Tailwinds Could Make International Stocks Fly for Years. Should You Buy Them?

International stocks are positioned to benefit from a valuation gap: the MSCI Total International Stock ETF trades at ~18x trailing P/E versus the S&P 500 at ~26.5x. The article argues the U.S. AI-premium is already priced (about a third of the S&P 500 at ~28x forward earnings, vs the MSCI ex-U.S. core at ~14.6x forward earnings), so rerating potential favors cheaper markets if AI-driven earnings materialize. It also cites China’s evolving foreign-investor framework (QFI I two-year plan for more transparency, plus a 2026 agenda on dividends/buybacks and tougher fraud penalties) as an additional catalyst for capital reallocation.

Analysis

The main market mechanism here is not “cheap versus expensive” in the abstract; it is concentration risk versus breadth. If AI-led U.S. earnings keep beating, the valuation gap can stay open, but any slowdown in megacap revisions would force passive and active allocators to reduce the embedded premium in QQQ-like exposure faster than they would need to re-underwrite overseas fundamentals. That makes the first-order winner IXUS-style breadth, while the second-order loser is the narrow cohort of U.S. mega-cap growth names whose multiples depend on flawless execution.

China is a separate catalyst, and the important point is that governance improvements only matter if they change expected cash returned to shareholders. BABA is the cleanest listed expression because a lower fraud/governance discount plus buyback visibility can move the multiple even before earnings accelerate; weaker Chinese ADRs without buyback capacity get less benefit. The broader spillover is that a credible framework for foreign capital could pull marginal money into emerging-market ETFs and away from U.S. growth on the margin over 6-18 months, especially if the dollar softens.

The main falsifier is a continuation of U.S. earnings breadth and a strong dollar: both would overwhelm the valuation argument and keep international underowned. Near term, this is more likely a positioning trade than a fundamentals trade, so it can reverse quickly on one or two strong AI earnings prints or if China policy language does not translate into measurable capital-return behavior within 1-2 quarters. The consensus may be underestimating how long structural discounts persist, but also overestimating how quickly a policy tweak in China rerates the whole asset class.

Key Decisions for Investors

• Modest tactical long IXUS vs short QQQ for 3-6 months; use the pair as a valuation/concentration trade, but size lightly because U.S. AI earnings can keep the spread wide. Falsify if QQQ forward EPS revisions keep accelerating or if IXUS underperforms by >5% after the next earnings cycle.
• Buy BABA on weakness as the highest-beta China governance beneficiary for a 6-12 month horizon; the trade works only if policy clarity turns into higher buybacks/dividends and fewer risk-premium shocks. Use a stop if ADR risk premium widens again on regulatory headlines.
• If expressing the theme via options, use call spreads on IXUS rather than outright calls; the move is more likely to be a gradual rerating than a squeeze. Best entry is after a U.S. tech-led rally, when relative valuation is most stretched.
• Avoid shorting NVDA solely on this thesis; if anything, treat it as a hedge against overbroad international rotation because continued AI capex can justify current multiples. Reassess only if forward revenue guidance slows for two consecutive quarters.
• Watch the dollar and China ADR policy implementation as catalysts; if DXY weakens and BABA begins returning materially more capital, increase exposure to international breadth and reduce U.S. mega-cap concentration.